Skip to Content

USL 070 (Potassium Citrate Extended-Release 5 mEq (540 mg))

Pill with imprint USL 070 is Tan, Round and has been identified as Potassium Citrate Extended-Release 5 mEq (540 mg). It is supplied by Upsher-Smith Laboratories, Inc.

Potassium citrate is used in the treatment of nephrolithiasis; renal tubular acidosis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 5 mEq (540 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for USL 070

Potassium citrate extended-release 5 mEq (540 mg) USL 070
Potassium citrate extended-release 5 mEq (540 mg) USL 070
Potassium citrate extended-release 5 mEq (540 mg) USL 070 Front
Potassium citrate extended-release 5 mEq (540 mg) USL 070 Back
Potassium citrate extended-release 5 mEq (540 mg) USL 070

Potassium Citrate Extended-Release

Imprint:
USL 070
Strength:
5 mEq (540 mg)
Color:
Tan
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary pH modifiers
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Upsher-Smith Laboratories, Inc
Inactive Ingredients:
carnauba wax
magnesium stearate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide